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Introduction
The legalization of cannabis and shift-
ing cultural attitudes have driven an
increase in cannabis use and the pro-
liferation of vapor delivery devices.
The DSM-V recognizes “cannabis use
disorder” under the umbrella of sub-
stance use disorders, but its neural
mechanisms require greater clarity
(Peters et al., 2020). Debate in the sci-
entific community and the public
sphere alike primarily asks, “is canna-
bis addictive?” and “are there negative
effects from chronic use?” The first
issue magnifies the second: if users
compulsively seek cannabis or become
dependent, then safe regimens become
difficult to maintain.
Drug abuse studies in human popula-
tions generally are confounded by use of
other drugs, medical history, and varying
genetic background. Self-administration in
animal models sidesteps these issues and
has good construct validity given the voli-
tional consumption (Koob et al., 2012).
Unlike cocaine and opioid self-administra-
tion studies, however, self-administration
of cannabis or D9-tetrahydrocannabinol
(THC) alone has been notoriously difficult
to establish across several species because
of THC’s weak rewarding effect and aver-
sive effects at high doses (Justinova et al.,
2005; Fuchs et al., 2019). Although THC is
the primary psychoactive compound
in cannabis, extracts may have over
120 other phytocannabinoids, including
cannabidiol (CBD), which has its own
effects as an inverse agonist at cannabi-
noid receptors (Ibsen et al., 2017).
Further complicating self-administra-
tion is the varying pharmacokinetics of
different delivery methods. In particu-
lar, intravenous delivery, which is used
for other addictive drugs, leads to fast
infusion rates that trigger aversive
effects for THC (Carbuto et al., 2012).
Freels et al. (2020) addressed these
long-standing issues by designing a
vapor-delivery method to successfully
establish cannabis self-administration
in rodents. Their paradigm bears the
greatest similarity to human use to
date by allowing volitional and titrata-
ble vapor delivery of cannabis extracts
(MacCallum and Russo, 2018). The
National Institute on Drug Abuse drug
supply program provided whole can-
nabis extract enriched with either
THC (CANTHC) or CBD (CANCBD). In
the apparatus, rats could nose-poke to
activate one of two ports indicated by a 60 s
light cue. When one port was activated,
one of three vapors was delivered: organic
solvent vehicle, CANTHC, or CANCBD;
when the other port was activated, nothing
was delivered.
CANTHC uniquely reinforces
self-administration by acting on
cannabinoid receptor type 1
(CB1)
Freels et al. (2020) demonstrated that
Sprague Dawley rats will stably self-admin-
ister CANTHC and perform more work for
a single delivery of CANTHC vapor than for
CANCBD or vehicle. Across fixed ratios of
nose-pokes to vapor deliveries, rats main-
tained a consistent number of CANTHC
vapor deliveries in each session, and the
number of deliveries was significantly
higher than for CANCBD or vehicle (;5 to
;12 deliveries/day, a baseline for nose-
poking). In all experiments, Freels et al.
(2020) observed some level of nose-poking
for the vehicle delivery, suggesting some
interest in the cue light and/or solvent
vapor. Even under the 1:1 ratio, however,
rats did not respond significantly more for
CANCBD than for vehicle. Furthermore,
when the rats faced a sequentially increasing
number of nose-pokes required to earn
vapor delivery, they worked significantly
more for CANTHC, but not for CANCBD,
than for vehicle. Notably, rats nose-poked
for CANTHC most often in the first 15min
of each 1 h session. These results suggest
that rats learn to nose-poke at a certain rate
to achieve a desired THC level. Maintaining
CANTHC consumption under a mounting
workload points to the drug’s reinforcing ef-
ficacy and is comparable with the human
motivation to devote time and effort to seek
an appealing stimulus (Fuchs et al., 2019).
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Freels et al. (2020) found that systemic
injection of AM251, a CB1-selective antag-
onist, reduced the CANTHC vapor seeking
rate to vehicle control levels, whereas the
CANCBD group was unaffected. While
CB1 is widely expressed across the mam-
malian brain, a well-characterized mid-
brain reward mechanism implicated in the
self-administration of other addictive sub-
stances likely underlies CANTHC’s effect
(Gardner, 2005). THC acts as partial ago-
nist of CB1, which is abundantly expressed
in VTA GABAergic terminals (Sperlágh et
al., 2009). In the VTA, the activation of
CB1 diminishes the GABAergic inhibition
of dopaminergic neurons that project to
the NAc (Gardner, 2005; Peters et al.,
2020). The resulting increase in dopami-
nergic tone in the NAc is rewarding and
can establish drug addiction (Peters et al.,
2020).
THC:CBD ratio in extracts
determines selectivity in self-
administration and presentation
of the tetrad response
Surprisingly, although rats were not will-
ing to work as hard to earn CANCBD as
they were to earn CANTHC, they self-
administered CANCBD more selectively. In
the behavior apparatus, the rats could
learn which port provided any vapor as
opposed to no outcome. Only the rats
earning CANCBD achieved a fraction of
nose-pokes at the active port that was sig-
nificantly greater than the vehicle group.
Quantification of cannabinoid concentra-
tions in the rat brain likely explains this
finding. Each of the two cannabis extracts
had a small quantity of the nonenriched
compound. CANTHC extract had a THC
concentration nearly 30 that of CANCBD
and a CBD concentration only 1/40 that of
CANCBD. Nonetheless, after self-adminis-
tration, brain THC concentrations were
similar regardless of which extract was
delivered, whereas the concentration of
CBD was ;3 greater in rats receiving
CANCBD than in those receiving CANTHC.
These results demonstrate that rats achieve
pharmacologically relevant increases in
brain THC with both extracts; the enrich-
ment of THC in the CANCBD group might
result from inhibition of THC metabo-
lism by CBD (Jones and Pertwee, 1972).
Furthermore, because THC disrupts
spatial memory and acquisition of
operant tasks in rats, it may increase
the error in discrimination (Varvel et
al., 2001; Delatte et al., 2002). Finally,
CBD counteracts the psychotropic and
aversive effects of THC particularly
through action in the ventral hippocampus
(Hudson et al., 2019). A balance between
THC-driven motivation and CBD-pro-
tected learning may therefore underlie the
discrimination disparity across CANTHC
and CANCBD groups.
In a separate experiment, the rats’
locomotion and metabolic parameters
were measured over 10 d of fixed-ratio
self-administration. Only rats that self-
administered CANTHC exhibited some
features of the classical physiological
“tetrad” response: lowered spontaneous
activity, antinociception, hypothermia,
and catalepsy (Metna-Laurent et al.,
2017). Rats self-administering CANTHC
spent more time inactive than those
receiving CANCBD but also displayed
significantly greater food consumption
and energy expenditure. In contrast,
locomotor and metabolic signatures
were indistinguishable in the CANCBD
and vehicle groups. This demonstrates
that the extracts have different effects
on some internal states (e.g., arousal
and appetite). Still, the mechanism that
relates drug action to internal state and
physiological adaptations that lead to
self-administration selectivity or chronic
drug seeking is not yet clear.
Self-administration of CANCBD
is more resistant to
extinguishing while CANTHC
elicits stronger reinstatement,
raising questions about the
underlying circuit adaptations
Freels et al. (2020) trained another cohort
of rats to self-administer vapor over 19 d
and then continued sessions with both
ports set as inactive over 7 d. The CANCBD
group, but not the CANTHC group,
required significantly more trials than the
vehicle group to extinguish nose-poking
(defined as a 50% decrease in nose-pokes
at the previously active port since the last
session with vapor delivery). Transitioning
the rats off of the vapor thus raised an
apparent inconsistency with the prior
results: rats were more resistant to extin-
guishing the seeking of CANCBD despite
their greater motivation to consume
CANTHC. This observation is especially
curious given that CBD disrupts the asso-
ciation between rewarding effect and the
spatial location where rats consume
cocaine or opioids (de Carvalho and
Takahashi, 2017; Mahmud et al., 2017).
The result might be explained by a differ-
ence in learning rates due to reward
prediction error for dopamine reinforce-
ment (Glimcher, 2011). The light cue or
vapor smell may be more salient to the
CANTHC group because they experience
the reinforcing effect of higher THC con-
centrations immediately. The CANTHC
group may have then experienced a greater
unexpected result under extinguishing con-
ditions, eliciting a faster rate of learning to
stop nose-poking.
Finally, to test the reinstatement of
vapor seeking, Freels et al. (2020) provided
an additional session after extinction, in
which nose-poking the previously active
port triggered the light cue, but no vapor
delivery. Only rats previously receiving
CANTHC increased their nose-poking rela-
tive to the vehicle group. This result indi-
cates a sustained stronger motivation to
seek CANTHC and is consistent with the
previous results indicating that CANTHC
has a greater reinforcing efficacy com-
pared with that of CANCBD. This drive to
seek CANTHC could be motivated by
reward-seeking, withdrawal avoidance, or
a combination of both factors (Fuchs et
al., 2019).
The study of cannabis use disorder is
now challenged with distinguishing the
actions of each cannabis constituent in the
development and reinforcement of malad-
aptive behaviors. Future work should
characterize the pharmacokinetics for the
method developed by Freels et al. (2020),
given that human use of electronic can-
nabis vaporization demands considerable
optimization (Hazekamp et al., 2006).
Then, one could determine whether syn-
thetic agonists, purified THC and CBD, or
cannabis extracts are sufficient to establish
self-administration. The work by Freels
et al. (2020) also raises questions about
reward encoding and prediction mecha-
nisms. The critical question for addiction
studies remains: what, if any, factor could
transition an animal from controlled to
compulsive cannabis seeking that forgoes
well-being (Everitt et al., 2008)? Freels et
al. (2020) have provided the behavioral
neuroscience field with a method to
address these questions with excellent fi-
delity to the human experience of canna-
bis use.
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